Time to diagnosis and mortality in colorectal cancer: a cohort study in primary care

por Tørring, M L, Frydenberg, M, Hansen, R P, Olesen, F, Hamilton, W, Vedsted, P
Publicado 2011

Targeting SDF-1/CXCR4 to inhibit tumour vasculature for treatment of glioblastomas

por Tseng, D, Vasquez-Medrano, D A, Brown, J M
Publicado 2011

Coffee intake and oral–oesophageal cancer: follow-up of 389 624 Norwegian men and women 40–45 years

por Tverdal, A, Hjellvik, V, Selmer, R
Publicado 2011

Objective assessment of tumour response to therapy based on tumour growth kinetics

por Mehrara, E, Forssell-Aronsson, E, Bernhardt, P
Publicado 2011

Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies

Publicado 2011

Stem cells, quiescence and rectal carcinoma: an unexplored relationship and potential therapeutic target

por Buczacki, S, Davies, R J, Winton, D J
Publicado 2011

Cold plasma selectivity and the possibility of a paradigm shift in cancer therapy

por Keidar, M, Walk, R, Shashurin, A, Srinivasan, P, Sandler, A, Dasgupta, S, Ravi, R, Guerrero-Preston, R, Trink, B
Publicado 2011

Influence of eicosapentaenoic acid supplementation on lean body mass in cancer cachexia

por Murphy, R A, Yeung, E, Mazurak, V C, Mourtzakis, M
Publicado 2011

Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells

por Ioannou, N, Dalgleish, A G, Seddon, A M, Mackintosh, D, Guertler, U, Solca, F, Modjtahedi, H
Publicado 2011

Antithrombotic therapy and survival in patients with malignant disease

por Kakkar, A K, Macbeth, F
Publicado 2010

Apoptosome-dependent caspase activation proteins as prognostic markers in Stage II and III colorectal cancer

por Hector, S, Conlon, S, Schmid, J, Dicker, P, Cummins, R J, Concannon, C G, Johnston, P G, Kay, E W, Prehn, J H M
Publicado 2012

Occupational cancer in Britain: Statistical methodology

por Hutchings, Sally J, Rushton, Lesley
Publicado 2012

Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model

por Kususda, Y, Miyake, H, Gleave, M E, Fujisawa, M
Publicado 2012

Mammographic density and molecular subtypes of breast cancer

por Eriksson, L, Hall, P, Czene, K, dos Santos Silva, I, McCormack, V, Bergh, J, Bjohle, J, Ploner, A
Publicado 2012

Luminal membrane expression of mesothelin is a prominent poor prognostic factor for gastric cancer

por Einama, T, Homma, S, Kamachi, H, Kawamata, F, Takahashi, K, Takahashi, N, Taniguchi, M, Kamiyama, T, Furukawa, H, Matsuno, Y, Tanaka, S, Nishihara, H, Taketomi, A, Todo, S
Publicado 2012

A systemic review of Toxic Death in clinical oncology trials: an Achilles’ heel in safety reporting revisited

por Penninckx, B, Van de Voorde, W M, Casado, A, Reed, N, Moulin, C, Karrasch, M
Publicado 2012

Normal tissues toxicities triggered by combined anti-angiogenic and radiation therapies: hurdles might be ahead

por Mangoni, M, Vozenin, M-C, Biti, G, Deutsch, E
Publicado 2012

Identifying patients with undetected colorectal cancer: an independent validation of QCancer (Colorectal)

por Collins, G S, Altman, D G
Publicado 2012

Microbubble and ultrasound radioenhancement of bladder cancer

por Tran, W T, Iradji, S, Sofroni, E, Giles, A, Eddy, D, Czarnota, G J
Publicado 2012

Recruitment of ethnic minorities into cancer clinical trials: experience from the front lines

por Symonds, R P, Lord, K, Mitchell, A J, Raghavan, D
Publicado 2012